These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 2826851)
21. Predictive role of serum procollagen III peptide and Knodell's index in survival prognosis of patients with hepatitis B virus liver cirrhosis. Babić Z; Bilić A; Babić D; Jagić V; Nikolić B; Sunić M Wien Klin Wochenschr; 2003 May; 115(9):302-8. PubMed ID: 12793031 [TBL] [Abstract][Full Text] [Related]
22. Is determination of serum N-terminal procollagen type III peptide (sPIIIP) a marker of hepatic fibrosis? Surrenti C; Casini A; Milani S; Ambu S; Ceccatelli P; D'Agata A Dig Dis Sci; 1987 Jul; 32(7):705-9. PubMed ID: 3595382 [TBL] [Abstract][Full Text] [Related]
23. The blue glass and the predictive value of serum amino-terminal propeptide of type III procollagen as a marker of liver fibrosis. Rojkind M Hepatology; 1984; 4(5):977-8. PubMed ID: 6479861 [No Abstract] [Full Text] [Related]
24. Type III procollagen amino terminal propeptide: what does it measure in children? Wootton CI; Murphy R Br J Dermatol; 2012 Dec; 167(6):1391-2. PubMed ID: 22578183 [No Abstract] [Full Text] [Related]
25. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Guéchot J; Laudat A; Loria A; Serfaty L; Poupon R; Giboudeau J Clin Chem; 1996 Apr; 42(4):558-63. PubMed ID: 8605673 [TBL] [Abstract][Full Text] [Related]
26. Serum markers for fibrosis and plasma transforming growth factor-beta 1 in patients with hepatocellular carcinoma in comparison with patients with liver cirrhosis. Murawaki Y; Ikuta Y; Nishimura Y; Koda M; Kawasaki H J Gastroenterol Hepatol; 1996 May; 11(5):443-50. PubMed ID: 8743916 [TBL] [Abstract][Full Text] [Related]
27. [Usefulness of measuring the level of procollagen type III peptide in the evaluation of liver fibrosis in children]. Swiatkowska E; Socha J; Bogoniowska Z; Leśniewska A; Malenta G; Oralewska B Pol Tyg Lek; 1988 Apr; 43(14):441-3. PubMed ID: 3412979 [No Abstract] [Full Text] [Related]
28. [Clinical significance of serum prolyl hydroxylase beta-subunit levels determined using monoclonal antibody]. Yasuhara M; Matsuda Y; Takada A Nihon Shokakibyo Gakkai Zasshi; 1987 Jun; 84(6):1225-32. PubMed ID: 2822982 [No Abstract] [Full Text] [Related]
29. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Niemelä O; Risteli L; Sotaniemi EA; Risteli J Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726 [TBL] [Abstract][Full Text] [Related]
30. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. Zachariae H; Søgaard H; Heickendorff L Acta Derm Venereol; 1989; 69(3):241-4. PubMed ID: 2566230 [TBL] [Abstract][Full Text] [Related]
31. [Procollagen III and laminin in chronic viral hepatopathies]. Montalto G; Soresi M; Aragona F; Tripi S; Carroccio A; Anastasi G; Magliarisi C; Barresi E; Notarbartolo A Presse Med; 1996 Jan; 25(2):59-62. PubMed ID: 8745719 [TBL] [Abstract][Full Text] [Related]
32. [A new determination method of type IV collagen in sera and its clinical significance in relation to hepatic fibrosis]. Suzuki H; Suzuki M; Kato Y; Okabe K; Uchikoshi T Nihon Shokakibyo Gakkai Zasshi; 1988 Aug; 85(8):1569. PubMed ID: 2846928 [No Abstract] [Full Text] [Related]
33. Serum type I collagen and N-terminal peptide of type III procollagen in chronic hepatitis. Relationship to liver histology and conventional liver tests. Trinchet JC; Hartmann DJ; Pateron D; Laarif M; Callard P; Ville G; Beaugrand M J Hepatol; 1991 Mar; 12(2):139-44. PubMed ID: 1711064 [TBL] [Abstract][Full Text] [Related]
34. Serum markers of hepatic fibrogenesis in chronic hepatitis type C treated with alfa-2A interferon. Gallorini A; Plebani M; Pontisso P; Chemello L; Masiero M; Mantovani G; Alberti A Liver; 1994 Oct; 14(5):257-64. PubMed ID: 7997085 [TBL] [Abstract][Full Text] [Related]
35. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease. Misaki M; Shima T; Yano Y; Sumita Y; Kano U; Murata T; Watanabe S; Suzuki S Clin Chem; 1990 Mar; 36(3):522-4. PubMed ID: 2311224 [TBL] [Abstract][Full Text] [Related]
36. Laminin and procollagen-III-peptide as a serum marker for hepatic fibrosis in congenital biliary atresia. Sasaki F; Hata Y; Hamada H; Takahashi H; Uchino J J Pediatr Surg; 1992 Jun; 27(6):700-3. PubMed ID: 1501026 [TBL] [Abstract][Full Text] [Related]
37. Serum type III procollagen peptide concentrations in severe chronic active hepatitis: relationship to cirrhosis and disease activity. McCullough AJ; Stassen WN; Wiesner RH; Czaja AJ Hepatology; 1987; 7(1):49-54. PubMed ID: 3492417 [TBL] [Abstract][Full Text] [Related]
38. Procollagen type III peptide in asymptomatic children with alpha 1-antitrypsin deficiency. Eriksson S; Sveger T J Pediatr Gastroenterol Nutr; 1988; 7(6):938-9. PubMed ID: 3264336 [No Abstract] [Full Text] [Related]
39. Three serum markers of collagen biosynthesis in Nigerians with cirrhosis and various infectious diseases. Bolarin DM; Savolainen ER; Kivirikko KI Eur J Clin Invest; 1984 Apr; 14(2):90-5. PubMed ID: 6329766 [TBL] [Abstract][Full Text] [Related]
40. Serum levels of aminoterminal type III procollagen peptide in normal subjects and hepatic fibrosis. Nakano H; Nakabayashi H; Okamoto Y; Kawasaki T; Seko S; Fukuda Y Gastroenterol Jpn; 1985 Dec; 20(6):573-6. PubMed ID: 4085749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]